The role of miR-143-3p/FNDC1 axis on the progression of non-small cell lung cancer
In conclusion, FNDC1 promotes the malignant prototypes of NSCLC cells. miR-143-3p is a negative regulator of FNDC1 in NSCLC cells, which may serve as a promising therapeutic target in NSCLC.
Source: European Journal of Histochemistry - Category: Biomedical Science Authors: Zhanshu Ma, Qi Gao, Wenjing Xin, Lei Wang, Yan Chen, Chang Su, Songyan Gao, Ruiling Sun Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Study